NCT07696559Completed
Effect of the β-sitosterol-enriched Dietary Plan on Lipid Levels.
Effects of β-sitosterol -Enriched Dietary Intervention on Lipid Profile to Alleviate Hyperlipidemia Among Grade II Obese Individuals
Source: ClinicalTrials.gov · Last updated 10 Jul 2026
Brief summary (registry, in English)
The purpose of the study is to assess the effect of β -Sitosterol enriched dietary intervention on lipid profile to alleviate hyperlipidemia among Grade II obese patients
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 6 Jul 2026
- Start date
- 15 Jan 2026
- Primary completion date
- 15 Mar 2026
- Lead sponsor
- University of Lahore
- Diseases
- Obesity
- NCT number
- NCT07696559
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 15 Jan 2026 to the primary completion date, 15 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with sitosterolemia, kidney or liver diseases
- Individuals with food allergies to any prescribed ingredients
Other
- Pregnant or lactating women
- Current use of statins, fibrates, or plant sterol supplements
Who the study is looking for
- Adults aged 25-55 years
- Diagnosed with hyperlipidemia (LDL ≥ 130 mg/dL or Total Cholesterol ≥ 200 mg/dL)
- BMI between 35.0-39.9 kg/m²
- Willing to follow a prescribed diet plan for the entire study duration
Age in the registry: 25 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Lahore Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.